Lucy Broughton
Position | PhD Student |
---|---|
Qualifications | BPharm PGDipClinPharm PGCertPharm |
Research summary | Psychotropic medicines in pregnancy |
Memberships | PSNZ |
Clinical | Senior Clinical Editor for NZ Formulary |
Publications
Broughton, L. C., Medlicott, N. J., & Smith, A. J. (2021). Effectiveness of patient decision aids in women considering psychotropic medication use during pregnancy: A literature review. Archives of Women's Mental Health, 24, 569-578. doi: 10.1007/s00737-021-01118-3
Glue, P., Neehoff, S., Sabadel, A., Broughton, L., Le Nedelec, M., Shadli, S., McNaughton, N., & Medlicott, N. J. (2020). Effects of ketamine in patients with treatment-refractory generalized anxiety and social anxiety disorders: Exploratory double-blind psychoactive-controlled replication study. Journal of Psychopharmacology, 34(3), 267-272. doi: 10.1177/0269881119874457
Le Nedelec, M., Glue, P., Winter, H., Goulton, C., Broughton, L., & Medlicott, N. (2018). Acute low-dose ketamine produces a rapid and robust increase in plasma BDNF without altering brain BDNF concentrations. Drug Delivery & Translational Research, 8(3), 780-786. doi: 10.1007/s13346-017-0476-2